Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Deleted footer elements include the Moffitt sponsor attribution and the Helpful Links section. This reduces visibility of institutional affiliation and access to related resources on the study page.
    Difference
    0.2%
    Check dated 2026-02-18T04:08:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous funding-status notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:09:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding notice has been added to the page, and the revision version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:48:09.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays a glossary toggle and introduces a new 'Last Update Submitted that Met QC Criteria' timestamp, along with 'No FEAR Act Data' and a new revision label 'v3.4.0'. The previously shown items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:43:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A new Revision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:22:19.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new Locations section was added, including Florida as a site; the HHS Vulnerability Disclosure and the prior Florida Locations entry were removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:24:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.